Schizophrenia reporting increased 12.3% in the dementia group as compared to 9.3% in the non-dementia group (p<0.0001). There were over 4 million MDS assessments annually. demographics, diabetes, heart conditions, and functional status), we examined the relationship before and after the partnership. Employing a difference-in-difference analysis adjusting for independent variables (e.g. Using a quasi-experimental study design, we examined changes in schizophrenia reporting among long-stay NH residents’ quarterly and/or yearly Minimum Data Set 3.0 assessments between 2011-2015. Given known health disparities and higher antipsychotic use for Black NH residents, we examined how race and dementia influence the rate of schizophrenia diagnoses. Preliminary research demonstrated an increase in the reporting of schizophrenia diagnoses among nursing home (NH) residents subsequent to the Centers for Medicare & Medicaid Services (CMS) National Partnership to Improve Dementia Care. Hispanics started with the highest rate of APM use and experienced the greatest decreases over time and with the new star rating measure.
The policy change did result in a one-time, significant drop in APM use, but did not alter the rate of decline already in place, presumably stemming from the National Partnership instituted in 2012. All three races experienced significant declines in APM use prior to the addition of AP use into the quality rating (p 0.5). Baseline use of APMs among persons with dementia was 29.1% for Whites, 29.2% for Blacks, and 33.7% for Hispanics. There were about 1 million NH residents per quarter.
#LAUREL MEADOWS CMS NURSING HOME COMPARE SERIES#
We examined changes in APM use quarterly (2013-2016) using interrupted time series analyses, stratified by race/ethnicity. Using a quasi-experimental study design and Minimum Data Set (MDS) 3.0 assessments, we examined long-stay NH residents with dementia. We examined the impact of this policy decision on NH residents with dementia by race/ethnicity. In 2015, the Centers for Medicare & Medicaid Services added inappropriate APM use to their NH 5-star quality ratings. Due to their potential to increase falls and death in people with dementia, antipsychotic medications (APMs) have been the subject of several federal efforts to reduce their use in nursing homes (NHs).
0 kommentar(er)
